Dépôt numérique
RECHERCHER

Detection of IKKε by immunohistochemistry in primary breast cancer: association with EGFR expression and absence of lymph node metastasis

Williams, Virginie; Grosset, Andrée-Anne; Zamorano Cuervo, Natalia; St-Pierre, Yves; Sylvestre, Marie-Pierre; Gaboury, Louis; Grandvaux, Nathalie (2017). Detection of IKKε by immunohistochemistry in primary breast cancer: association with EGFR expression and absence of lymph node metastasis BMC Cancer , vol. 17 , nº 356. DOI: 10.1186/s12885-017-3321-6.

[img]
Prévisualisation
PDF - Version publiée
Disponible sous licence Creative Commons Attribution.

Télécharger (1MB) | Prévisualisation

Résumé

BACKGROUND: IKKε is an oncogenic kinase that was found amplified and overexpressed in a substantial percentage of human breast cancer cell lines and primary tumors using genomic and gene expression analyses. Molecular studies have provided the rational for a key implication of IKKε in breast cancer cells proliferation and invasiveness through the phosphorylation of several substrates.

METHODS: Here, we performed immunohistochemical detection of IKKε expression on tissue microarrays constituted of 154 characterized human breast cancer tumors. We further determined the association with multiple clinicopathological parameters and 5-years overall, disease-free and distant disease free survival.

RESULTS: We observed expression of IKKε in 60.4% of the breast cancer tumors. IKKε expression status showed no association with a panel of markers used for molecular classification of the tumors, including ER/PR/HER2 status, or with the molecular subtypes. However, IKKε expression was inversely associated with lymph node metastasis status (p = 0.0032). Additionally, we identified a novel association between IKKε and EGFR expression (p = 0.0011).

CONCLUSIONS: The unexpected observation of an inverse association between IKKε and lymph node metastasis advocates for larger scale immunohistochemical profiling of primary breast tumors to clarify the role of IKKε in metastasis. This study suggests that breast cancer tumors expressing EGFR and IKKε may be potential targets for drugs aiming at inhibiting IKKε activity or expression.

Type de document:
Mots-clés libres: Biomarker; Breast; Cancer; EGFR; IKKε; Immunohistochemistry; Metastasis; Prognosis
Centre: Centre INRS-Institut Armand Frappier
Date de dépôt: 29 juin 2017 05:16
Dernière modification: 29 juin 2017 05:16
URI: http://espace.inrs.ca/id/eprint/5292

Actions (Identification requise)

Modifier la notice Modifier la notice